Results 21 to 30 of about 1,874,188 (207)

Oral Cholera Vaccine Efficacy and Effectiveness. [PDF]

Vaccines (Basel), 2021
Although measuring vaccine efficacy through the conventional phase III study design, randomized, double-blinded controlled trial serves as the “gold standard”, effectiveness studies, conducted in the context of a public health program, seek to broaden the understanding of the impact of a vaccine in a real world setting including both individual and ...
Song KR, Lim JK, Park SE, Saluja T, Cho SI, Wartel TA, Lynch J.   +6 more
europepmc   +6 more sources

Oral Vaccines Against Cholera [PDF]

Clinical Infectious Diseases, 2011
The current seventh pandemic of cholera, caused by serogroup O1, El Tor biotype, has now involved almost the entire developing world. The ongoing dynamic epidemiology of cholera, involving evolution of new strains, prolonged and more frequent epidemics, increased antimicrobial resistance, and awareness of the role of climate change upon the global ...
Sunheang, Shin, Sachin N, Desai, Binod K, Sah, John D, Clemens   +3 more
openaire   +2 more sources

Oral vaccines for preventing cholera [PDF]

Cochrane Database of Systematic Reviews, 2010
This review is superseded by the published Cochrane Review, Saif‐Ur‐Rahman 2024 [https://doi.org/10.1002/14651858.CD014573], which considers only the oral killed vaccines because the live oral vaccines do not have World Health Organization (WHO) prequalification. Saif‐Ur‐Rahman 2024 also considered only currently available WHO pre‐qualified oral killed
Sinclair, David, Abba, Katharine, Zaman, K., Qadri, Firdausi, Graves, Patricia M.   +4 more
openaire   +3 more sources

An Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, India. [PDF]

PLoS Neglected Tropical Diseases, 2015
BACKGROUND:Service provider costs for vaccine delivery have been well documented; however, vaccine recipients' costs have drawn less attention. This research explores the private household out-of-pocket and opportunity costs incurred to receive free oral
Vittal Mogasale, Shantanu K Kar, Jong-Hoon Kim, Vijayalaxmi V Mogasale, Anna S Kerketta, Bikash Patnaik, Shyam Bandhu Rath, Mahesh K Puri, Young Ae You, Hemant K Khuntia, Brian Maskery, Thomas F Wierzba, Binod Sah   +12 more
doaj   +1 more source

A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh [PDF]

, 2022
Bangladesh remains cholera endemic with biannual seasonal peaks causing epidemics. At least 300,000 severe cases and over 4,500 deaths occur each year. The available oral cholera vaccines have not yet been adopted for cholera control in Bangladesh due to
Ahmed, Faez, Tauheed, Imam, Akter, Afroza, Sil, Arijit, Basher, Salima Raiyan, Ahasan, Mohammad Mainul, Masud, Mir Mohammad Ibna, Teshome, Samuel, Chon, Yun, Ferdous, Jannatul, Mia, Masudur Rahman, Park, Ju Yeon, Bhuiyan, Taufiqur Rahman, Karim, Mahbubul, Chowdhury, Fahima, et al., Abdul Wahab Khan, Mohammad Mainul Ahasan, Masudur Rahman Mia, Yun Chon, Jean-Louis Excler, Laura Digilio, Salima Raiyan Basher, Mir Mohammad Ibna Masud, Deok Ryun Kim, Mahbubul Karim, Taufiqur Rahman Bhuiyan, Arijit Sil, Samuel Teshome, Faez Ahmed, Md. Muktadir Rahman Ashik, Afroza Akter, Firdausi Qadri, Ju Yeon Park, Fahima Chowdhury, Masum Billah, Zebun Nahar, Imam Tauheed, Jannatul Ferdous, John D. Clemens, Julia Lynch, Allen G. Ross, Imran Khan   +42 more
core   +1 more source

Stemming cholera tides in Zimbabwe through mass vaccination

International Journal of Infectious Diseases, 2020
Background: In 2018, Zimbabwe declared another major cholera outbreak a decade after recording one of the worst cholera outbreaks in Africa. Methods: A mathematical model for cholera was used to estimate the magnitude of the cholera outbreak and ...
Zindoga Mukandavire, Portia Manangazira, Farai Nyabadza, Diego F Cuadros, Godfrey Musuka, J. Glenn Morris, Jr.   +5 more
doaj   +1 more source

Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings : a meta-analytic approach [PDF]

, 2016
Controlling cholera remains a significant challenge in Sub-Saharan Africa. In areas where access to safe water and sanitation are limited, oral cholera vaccine (OCV) can save lives. Establishment of a global stockpile for OCV reflects increasing priority
Merten, Sonja, Schaetti, Christian, Sundaram, Neisha, Claire-Lise Chaignat, Mitchell G. Weiss, Hutubessy, Raymond, Weiss, Mitchell G., Sonja Merten, Christian Schindler, Chaignat, Claire-Lise, Said M. Ali, Erick O. Nyambedha, Neisha Sundaram, Schindler, Christian, Raymond Hutubessy, Ali, Said M., Lapika, Bruno, Christian Schaetti, Bruno Lapika, Nyambedha, Erick O., Sundaram N, Schindler C, Schaetti C, Nyambedha EO, Lapika B, Weiss MG, Hutubessy R, Ali SM, Weiss, Mitchell, Merten S, Chaignat CL   +30 more
core   +1 more source

Social and cultural features of vaccine acceptance and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar [PDF]

, 2012
Classical cholera control is based on prevention—safe water, sanitation and education of people on the importance of hygiene and diarrheal diseases—health system preparedness and a timely response to provide appropriate treatment in the event of an ...
Schätti Zundel, Christian
core   +1 more source

Comparing sociocultural features of cholera in three endemic African settings [PDF]

, 2013
Cholera mainly affects developing countries where safe water supply and sanitation infrastructure are often rudimentary. Sub-Saharan Africa is a cholera hotspot.
Merten, Sonja, Schaetti, Christian, Sundaram, Neisha, Erick O Nyambedha, Claire-Lise Chaignat, Hutubessy, Raymond, Weiss, Mitchell G., Sonja Merten, Chaignat, Claire-Lise, Mitchell G Weiss, Neisha Sundaram, Raymond Hutubessy, Ali, Said M., Lapika, Bruno, Christian Schaetti, Said M Ali, Bruno Lapika, Nyambedha, Erick O., Sundaram N, Schaetti C, Nyambedha, Erick O, Nyambedha EO, Lapika B, Ali, Said M, Weiss MG, Hutubessy R, Ali SM, Weiss, Mitchell, Merten S, Chaignat CL   +29 more
core   +2 more sources

Single-Dose Oral Cholera Vaccine in Bangladesh [PDF]

New England Journal of Medicine, 2016
To the Editor: The reported 6-month efficacy of a single dose of oral cholera vaccine in Bangladesh (May 5 issue),1 although seemingly modest, may have profound implications for future use of the vaccine. One-year protection from two doses in India and Bangladesh did not differ significantly from these new results, a finding that suggests that short ...
Azman AS, Luquero FJ
openaire   +3 more sources